Summary
Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on April 7, 2008, reporting on personnel changes. The primary focus is the retirement of Dr. Randall Rupp, Senior Vice President of Manufacturing Operations, after over sixteen years of service. Dr. Rupp will officially retire on October 1, 2008, after commencing an unpaid leave of absence on April 1, 2008. During this leave, he will retain eligibility for medical and other employee benefits. As a consequence of his upcoming retirement, Dr. Rupp is no longer considered an executive officer and has been removed from the Company's Change in Control Severance Plan. Additionally, the company announced the promotion of Mr. Daniel Van Plew from Vice President and General Manager, Industrial Operations and Product Supply, to Senior Vice President and General Manager, Industrial Operations and Product Supply, effective April 4, 2008.
Key Highlights
- 1Dr. Randall Rupp, Senior Vice President of Manufacturing Operations, is retiring.
- 2Dr. Rupp's retirement is effective October 1, 2008, following an unpaid leave of absence starting April 1, 2008.
- 3Dr. Rupp will continue to receive medical and other employee benefits during his leave.
- 4Dr. Rupp is no longer an executive officer of the company as of April 4, 2008.
- 5Dr. Rupp is no longer a participant in Regeneron's Change in Control Severance Plan.
- 6Mr. Daniel Van Plew has been promoted to Senior Vice President and General Manager, Industrial Operations and Product Supply.
- 7The company expressed gratitude for Dr. Rupp's over sixteen years of service.